Geron reported $952.1M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amgen USD 209.65B 14.21B Aug/2026
Bio Techne USD 11.41B 3.24B Aug/2026
Cassava Sciences USD 82M 14M Mar/2026
Cytokinetics USD 9.6B 1.95B Aug/2026
Exelixis USD 15.27B 1.73B Aug/2026
Genmab DKK 126.96B 109.86B Aug/2026
Geron USD 979M 24M Aug/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
Incyte USD 26.84B 4.19B Aug/2026
MacroGenics USD 184M 82M Mar/2026
Novartis USD 240.59B 67.17B Jun/2026
Novavax USD 1.09B 316M Dec/2025